Company intelligence / Profile preview

Yongying Bio

Dalian (Jinpu New District), Liaoning, China

Ownership: Private
Employees: ~130
Development stage: Other

Overview

Yinyi Bio has developed and marketed third-generation polymer-free drug stents and drug-eluting balloons that fill domestic technology gaps in China; clinical performance results are not published in English sources.

Therapeutic areas: Cardiovascular
Modalities: DeviceDrug-eluting stentDrug-eluting balloonMetal stentBalloon catheter
Industry: Implantable Medical Devices

Partnerships

Cooperates with domestic first-level agents for sales; no major international pharmaceutical partnerships disclosed.

Beyond the preview

Go deeper on Yongying Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yongying Bio.

Explore the full profile